Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Na-GST-1 and Na-APR-1 Hookworm Vaccine in Gabonese Adults
NCT02126462Phase 1Completed
- Sponsor
- Baylor College of Medicine
- Start
- Nov 2014
- Primary completion
- Feb 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Necator americanus Glutathione-S-Transferase-1 and Na-APR-1 (M74) in hookworm infection (3 arms), sponsored by Baylor College of Medicine. Primary endpoint: Vaccine-related Adverse Events at Day 360. Started Nov 2014; status: completed.
02
Drugs
Necator americanus Glutathione-S-Transferase-1Na-APR-1 (M74)
03
Conditions
hookworm infection
Beyond the preview
Go deeper on NCT02126462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02126462.